Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Michael E. Wiebe"'
Autor:
Andrea L, Koenigsberg, Veronica, Fowler, Reuben, Domike, Audrey, Brussel, Paul W, Barone, Flora J, Keumurian, James, Leung, Michael E, Wiebe, Michael T, Brewer, Shawn, Chan, Nicolas, Dumey, Anne, Fournillier, Marcella, Goodnight, Johanna, Kindermann, Richard, Leavy, Buyoung, Lee, Stefan, Minning, Marie, Murphy, Eric, Myers, Armen, Nahabedian, Kavita, Nanda, Sandi, Parriott, G K, Raju, Ciaran, Scallan, Stephanie, Schoch, Joe, Shiminsky, Bonnie, Shum, Sebastian, Teitz, Bernice, Westrek, Stacy, Springs
Publikováno v:
PDA Journal of Pharmaceutical Science and Technology. 77:115-132
Some members of MIT's Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) previously published content on the ″Quality Risk Management in the Context of Viral Contamination″ which described tools, procedures, and methodolog
Autor:
Robert Kiss, Jacob Hoffman, Paul W. Barone, Joleen Su, Houman Dehghani, Shelley Alvarado, Jonathan Rice, Martina Kopp, Marie Murphy, Mark Bailey, Stacy L. Springs, Michael E. Wiebe, Dayue Chen
Publikováno v:
Biotechnology and Bioengineering. 118:2967-2976
In recent years, high temperature short time (HTST) treatment technology has been increasingly adopted for medium treatment to mitigate the potential risk of viral contamination in mammalian cell culture GMP manufacturing facilities. Mouse minute vir
Autor:
Rob Ballard, Stacy L. Springs, Audrey Brussel, Michael E. Wiebe, Flora J. Keumurian, James C. Leung, Paul W. Barone, Nguyen Ly, Sheldon Mink, Ian Hart, Christopher F. Dowd, Johanna Kindermann, Lionel Gerentes, Kerstin Nöske, Stephen Avgerinos, Stefan Minning, Bonnie Shum, Philip Clark, Jurgen Mullberg, Sandi Parriott, Marie Murphy
Publikováno v:
PDA Journal of Pharmaceutical Science and Technology. 73:191-203
Appropriate segregation within manufacturing facilities is required by regulators and utilized by manufacturers to ensure that the final product has not been contaminated with 1) adventitious viruses, 2) another pre-/ post-viral clearance fraction of
Principles of process validation are extremely powerful tools in assurance of product quality. They are especially useful for reducing those risks not easily measured routinely during production. When combined with effective process and facility desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cb43874c12a92329e83505571f0f2a9
https://doi.org/10.1201/9780203749166-19
https://doi.org/10.1201/9780203749166-19
Autor:
Mark Plavsic, Lionel Gerentes, Dan Gold, Jurgen Mullberg, Richard Snyder, James C. Leung, James F. Bouressa, Jacqueline Wolfrum, Richard Schicho, Anthony J. Sinskey, Robert Kiss, Michael Ruffing, Audrey Brussel, Houman Dehghani, Laurent Mallet, Paul W. Barone, Marie Murphy, Mark Moody, David J. Roush, Serge Monpoeho, Ming Chong, Nathan J. Roth, Yuling Li, Daniel Stark, Flora J. Keumurian, Chun Zhang, Dayue Chen, Christian Menzel, René Labatut, Thomas R. Kreil, James Gilbert, Michael E. Wiebe, Islam T. M. Hussein, Stacy L. Springs
Publikováno v:
Prof. Sinskey
Recombinant protein therapeutics, vaccines, and plasma products have a long record of safety. However, the use of cell culture to produce recombinant proteins is still susceptible to contamination with viruses. These contaminations cost millions of d
Publikováno v:
PDA Journal of Pharmaceutical Science and Technology. 65:544-546
CONFERENCE PROCEEDING Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1-3, 2010 Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) and Mic
Autor:
Michael E. Wiebe, Kathryn E. King
Publikováno v:
PDA journal of pharmaceutical science and technology. 65(6)
CONFERENCE PROCEEDING Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1-3, 2010 Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) and Mic
Publikováno v:
Virology. 110:197-201
Ten temperature-sensitive mutants of Venezuelan encephalitis virus were derived from a hamster-virulent strain by treatment with N -methyl- N′ -nitro- N -nitrosoguanidine. Three mutants were relatively thermolabile, and four were RNA − . No mutan
Autor:
Robert E. Shope, Robert B. Tesh, Charles H. Calisher, Frederick A. Murphy, Walter Brandt, Michael E. Wiebe, Nick Karabatsos, Jordi Casals
Publikováno v:
Intervirology. 14:229-232